Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Jon Williams

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|October 3, 2008
Molecular processes that handle -- and mishandle -- dietary lipidsKevin Jon Williams
Atherosclerosis|July 7, 2024
The value of a negative studyKevin Jon Williams
Atherosclerosis|July 10, 2012
What does HDL do? A new mechanism to slow atherogenesis--but a new problem in type 2 diabetes mellitusKevin Jon Williams
Current Opinion in Lipidology|January 23, 2025
Inflammation in atherosclerosis: a Big Idea that has underperformed so farKevin Jon Williams
Arteriosclerosis, Thrombosis, and Vascular Biology|May 22, 2009
Some things just have to be done in vivo: GPIHBP1, caloric delivery, and the generation of remnant lipoproteinsKevin Jon Williams
Arteriosclerosis, Thrombosis, and Vascular Biology|March 30, 2023
Arterial Zones That Take a Pause in Early Plaque DevelopmentKevin Jon Williams
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Editorial: The mystery--and importance--of diabetic atherosclerotic vascular diseaseKevin Jon Williams
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2023
Eradicating Atherosclerotic Events by Targeting Early Subclinical Disease: It Is Time to Retire the Therapeutic Paradigm of Too Much, Too LateKevin Jon Williams
Atherosclerosis|June 7, 2021
Corrigendum to "Imbalanced insulin action in chronic overnutrition: Clinical harm, molecular mechanisms, and a way forward" [Atherosclerosis 247 (April 2016) 225-282]Kevin Jon Williams, Xiangdong Wu
Circulation|June 1, 2006
Letter by Williams and Tabas regarding article "atherosclerosis 2005: recent discoveries and novel hypotheses"Kevin Jon Williams, Ira Tabas
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|October 3, 2008
Molecular processes that handle -- and mishandle -- dietary lipidsKevin Jon Williams
Atherosclerosis|July 7, 2024
The value of a negative studyKevin Jon Williams
Atherosclerosis|July 10, 2012
What does HDL do? A new mechanism to slow atherogenesis--but a new problem in type 2 diabetes mellitusKevin Jon Williams
Current Opinion in Lipidology|January 23, 2025
Inflammation in atherosclerosis: a Big Idea that has underperformed so farKevin Jon Williams
Arteriosclerosis, Thrombosis, and Vascular Biology|May 22, 2009
Some things just have to be done in vivo: GPIHBP1, caloric delivery, and the generation of remnant lipoproteinsKevin Jon Williams
Arteriosclerosis, Thrombosis, and Vascular Biology|March 30, 2023
Arterial Zones That Take a Pause in Early Plaque DevelopmentKevin Jon Williams
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Editorial: The mystery--and importance--of diabetic atherosclerotic vascular diseaseKevin Jon Williams
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2023
Eradicating Atherosclerotic Events by Targeting Early Subclinical Disease: It Is Time to Retire the Therapeutic Paradigm of Too Much, Too LateKevin Jon Williams
Atherosclerosis|June 7, 2021
Corrigendum to "Imbalanced insulin action in chronic overnutrition: Clinical harm, molecular mechanisms, and a way forward" [Atherosclerosis 247 (April 2016) 225-282]Kevin Jon Williams, Xiangdong Wu
Circulation|June 1, 2006
Letter by Williams and Tabas regarding article "atherosclerosis 2005: recent discoveries and novel hypotheses"Kevin Jon Williams, Ira Tabas
Pageof 9